Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer |
Kim, Da-Hyun
(Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine)
Lee, Seul (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine) Kang, Hyeok Gu (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine) Park, Hyun-Woo (Department of Biochemistry, College of Life Science, Yonsei University) Lee, Han-Woong (Department of Biochemistry, College of Life Science, Yonsei University) Kim, Dongin (R&D center, ABL Bio Inc.) Yoem, Dong-Hoon (R&D center, ABL Bio Inc.) Ahn, Jin-Hyung (R&D center, ABL Bio Inc.) Ha, Eunsin (R&D center, ABL Bio Inc.) You, Weon-Kyoo (R&D center, ABL Bio Inc.) Lee, Sang Hoon (R&D center, ABL Bio Inc.) Kim, Seok-Jun (Department of Biomedical Science, College of Natural Science, Chosun University) Chun, Kyung-Hee (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine) |
1 | Russo AE and Strong VE (2019) Gastric cancer etiology and management in asia and the west. Annu Rev Med 70, 353-367 DOI |
2 | Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R and Polkowski WP (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 10, 239-248 DOI |
3 | Kanat O, O'Neil B and Shahda S (2015) Targeted therapy for advanced gastric cancer: A review of current status and future prospects. World J Gastrointest Oncol 7, 401-410 DOI |
4 | Lin Y, Wu Z, Guo W and Li J (2015) Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. Tumour Biol 36, 7385-7394 DOI |
5 | Guruharsha KG, Kankel MW and Artavanis-Tsakonas S (2012) The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet 13, 654-666 DOI |
6 | Andersson ER, Sandberg R and Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612 DOI |
7 | Miao ZF, Xu H, Xu HM et al (2017) DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation. Cancer Med 6, 245-257 DOI |
8 | Hori K, Sen A and Artavanis-Tsakonas S (2013) Notch signaling at a glance. J Cell Sci 126, 2135-2140 DOI |
9 | Bagheri V, Memar B, Behzadi R et al (2018) Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. J Cell Physiol 233, 7036-7046 DOI |
10 | Ishigami S, Arigami T, Uenosono Y et al (2013) Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res 32, 46 DOI |
11 | Aster JC, Pear WS and Blacklow SC (2017) The Varied Roles of Notch in Cancer. Annu Rev Pathol 12, 245-275 DOI |
12 | Lee D, Kim D, Choi YB et al (2016) Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis. MAbs 8, 892-904 DOI |
13 | Bailly C (2019) Irinotecan: 25 years of cancer treatment. Pharmacol Res 148, 104398 DOI |
14 | Reim D, Loos M, Vogl F et al (2013) Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol 31, 263-271 DOI |
15 | Thuss-Patience PC, Kretzschmar A, Bichev D et al (2011) Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur J Cancer 47, 2306-2314 DOI |
16 | Pasquini G, Vasile E, Caparello C et al (2016) Third-line chemotherapy with irinotecan plus 5-fluorouracil in caucasian metastatic gastric cancer patients. Oncology 91, 311-316 DOI |
17 | Seo MD, Lee KW, Lim JH et al (2008) Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer. Jpn J Clin Oncol 38, 589-595 DOI |
18 | Sweeney TJ, Mailander V, Tucker AA et al (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 96, 12044-12049 DOI |
19 | den Dulk M, Verheij M, Cats A, Jansen EP, Hartgrink HH and Van de Velde CJ (2006) The essentials of locoregional control in the treatment of gastric cancer. Scand J Surg 95, 236-242 DOI |
20 | Kim IH (2019) Current status of adjuvant chemotherapy for gastric cancer. World J Gastrointest Oncol 11, 679-685 DOI |
21 | Fujita K, Kubota Y, Ishida H and Sasaki Y (2015) Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 21, 12234-12248 DOI |
22 | Chun JH, Kim HK, Lee JS et al (2004) Weekly irinotecan in patients with metastatic gastric cancer failing cisplatinbased chemotherapy. Jpn J Clin Oncol 34, 8-13 DOI |
23 | Katoh M and Katoh M (2020) Precision medicine for human cancers with Notch signaling dysregulation (Review). Int J Mol Med 45, 279-297 |
24 | Yamao T, Shirao K, Matsumura Y et al (2001) Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer. Ann Oncol 12, 1729-1735 DOI |
25 | Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL and Lewis J (2007) Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134, 839-844 DOI |
26 | Shutter JR, Scully S, Fan W et al (2000) Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 14, 1313-1318 |
27 | Chatterjee S, Heukamp LC, Siobal M et al (2013) Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest 123, 1732-1740 DOI |
28 | Fu L, Bu L, Yasuda T et al (2020) Gastric cancer stem cells: current insights into the immune microenvironment and therapeutic targets. Biomedicines 8, 7 DOI |
29 | Baek JH, Kim NJ, Song JK and Chun KH (2017) Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK). BMB Rep 50, 566-571 DOI |
30 | Kim NJ, Baek JH, Lee J, Kim H, Song JK and Chun KH (2019) A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling. Exp Mol Med 51, 5 DOI |
31 | Cho Y, Kang HG, Kim SJ et al (2018) Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death Differ 25, 1781-1795 DOI |